Formulation and evaluation of flucytosine-loaded nanoemulgel for enhanced antifungal activity through in vitro and in vivo studies

Rajat  Srivastava; Ajay Kumar Singh  Rawat

doi:10.69857/joapr.v13i6.1405

Authors

Rajat Srivastava Maharishi School of Pharmaceutical Sciences, Maharishi University of Information Technology, Lucknow, Uttar Pradesh, 226013, India
Ajay Kumar Singh Rawat Maharishi School of Pharmaceutical Sciences, Maharishi University of Information Technology, Lucknow, Uttar Pradesh, 226013, India

DOI:

https://doi.org/10.69857/joapr.v13i6.1405

Keywords:

Flucytosine, Nanoemulgel, In vitro and in Vivo Evaluation, Drug Release Kinetics, Antifungal Efficacy

Abstract

Background: Fungal skin infections constitute a prevalent global health issue, accompanied by increasing resistance to traditional antifungal medications. Flucytosine, a pyrimidine analogue exhibiting potent antifungal properties, is constrained in topical use due to inadequate skin absorption and fast elimination. Nanoemulgels, which integrate nanoemulsions with gels, enhance solubility, penetration, stability, and prolonged release, representing a viable approach for topical antifungal administration. Methods: The nanoemulgel was prepared utilizing Carbopol 940 as the gelling agent. The formulations (NEG1–NEG8) were evaluated for physical appearance, pH, viscosity, spreadability, drug content, and in vitro drug release and release kinetics. Antifungal activity was assessed by zone-of-inhibition assays and in vivo using Wistar rats infected with Candida albicans. Skin irritation, histopathology, and a three-month stability study were also conducted. Result and Discussion: The improved NEG5 formulation had a favorable pH (5.92±0.03), high drug content (95.3±1.83%), and maximum cumulative drug release (92.97±5.91% at 24 hours) with first-order release kinetics (R2= 0.9959). The commercial luliconazole cream and NEG5 showed increased antifungal effectiveness in vivo, with lesion clearance by Day 14. The histopathology showed tissue repair with minimal inflammation. NEG5 surpassed other formulations in zone-of-inhibition assays for antifungal activity. No skin irritation was reported, and the formulation was stable for three months under various storage conditions. The improved physicochemical and therapeutic performance of NEG5 suggests enhanced skin penetration and sustained drug release, addressing the limitations of conventional flucytosine therapies. Conclusion: Flucytosine-loaded nanoemulgel (NEG5) offers a promising, effective topical treatment for fungal skin infections with improved drug delivery and patient safety.

Downloads

Download data is not yet available.

References

Kaur M, Singh K, Jain SK. Luliconazole vesicular based gel formulations for its enhanced topical delivery. J. Liposome Res., 30, 388–406 (2020) https://doi.org/10.1080/08982104.2019.1682602

Chen L, Zhang L, Xie Y, Wang Y, Tian X, Fang W, Xue X, Wang L. Confronting antifungal resistance, tolerance, and persistence: advances in drug target discovery and delivery systems. Adv. Drug Deliv. Rev., 200, 115007 (2023) https://doi.org/10.1016/j.addr.2023.115007

Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, Okoroafor CC, Eze SC, Kalu OL, Odoh EC. Advances in drug delivery systems, challenges and future directions. Heliyon, 9, e17488 (2023) https://doi.org/10.1016/j.heliyon.2023.e17488

Zhao L, Chen J, Bai B, Song G, Zhang J, Yu H, Huang S, Wang Z, Lu G. Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing. Front. Pharmacol., 14, 1333986 (2024) https://doi.org/10.3389/fphar.2023.1333986

Duarte J, Sharma A, Sharifi E, Damiri F, Berrada M, Khan MA, Singh SK, Dua K, Veiga F, Mascarenhas-Melo F, Pires PC, Paiva-Santos AC. Topical delivery of nanoemulsions for skin cancer treatment. Appl. Mater. Today, 35, 102001 (2023) https://doi.org/10.1016/j.apmt.2023.102001

Lal DK, Kumar B, Saeedan AS, Ansari MN. An overview of nanoemulgels for bioavailability enhancement in inflammatory conditions via topical delivery. Pharmaceutics, 15, 1187 (2023) https://doi.org/10.3390/pharmaceutics15041187

Sharaff CS, Renukuntla P, Peddapalli H, Kuchukuntla M, Bakshi V, Jadi RK. Formulation, Development, and Characterization of Loratadine Emulgel. Journal of Applied Pharmaceutical Research, 12, 42–50 (2024) https://doi.org/10.18231/j.joapr.2024.12.2.42.50.

Alffenaar JW, van Hateren K, Touw DJ. Determination of flucytosine in human serum using liquid chromatography-tandem mass spectrometry. J. Appl. Bioanal., 4, 157–65 (2018) http://dx.doi.org/10.17145/jab.18.020

Sigera LSM, Denning DW. Flucytosine and its clinical usage. Ther. Adv. Infect. Dis., 10, 20499361231161388 (2023) https://doi.org/10.1177/20499361231161

Tayah DY, Eid AM. Development of miconazole nitrate nanoparticles loaded in nanoemulgel to improve its antifungal activity. Saudi Pharm. J., 31, 526–34 (2023) https://doi.org/10.1016/j.jsps.2023.02.005

Sadozai SK, Khan SA, Baseer A, Ullah R, Zeb A, Schneider M. In vitro, ex vivo, and in vivo evaluation of nanoparticle-based topical formulation against Candida albicans infection. Front. Pharmacol., 13, 909851 (2022) https://doi.org/10.3389/fphar.2022.909851

Donthi MR, Munnangi SR, Krishna KV, Saha RN, Singhvi G, Dubey SK. Nanoemulgel: a novel nano carrier as a tool for topical drug delivery. Pharmaceutics, 15, 164 (2023) https://doi.org/10.3390/pharmaceutics15010164

Shi Y, Zhang M, Chen K, Wang M. Nano-emulsion prepared by high pressure homogenization method as a good carrier for Sichuan pepper essential oil: preparation, stability, and bioactivity. LWT, 154, 112779 (2022) https://doi.org/10.1016/j.lwt.2021.112779

Khani S, Keyhanfar F, Amani A. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Deliv., 23, 2035–43 (2016) https://doi.org/10.3109/10717544.2015.1088597

Khan BA, Ahmad N, Alqahtani A, Baloch R, Rehman AU, Khan MK. Formulation development of pharmaceutical nanoemulgel for transdermal delivery of feboxostat: physical characterization and in vivo evaluation. Eur. J. Pharm. Sci., 195, 106665 (2024) https://doi.org/10.1016/j.ejps.2023.106665

Chaudhary H, Rohilla A, Rathee P, Kumar V. Optimization and formulation design of Carbopol loaded piroxicam gel using novel penetration enhancers. Int. J. Biol. Macromol., 55, 246–53 (2013) https://doi.org/10.1016/j.ijbiomac.2013.01.015

Kakkar V, Kaur IP, Kaur AP, Saini K, Singh KK. Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study. Drug Dev. Ind. Pharm., 44, 1701–12 (2018) https://doi.org/10.1080/03639045.2018.1492607

Yılmaz Usta D, Teksin ZS, Tugcu-Demiroz F. Evaluation of emulgel and nanostructured lipid carrier-based gel formulations for transdermal administration of ibuprofen: characterization, mechanical properties, and ex vivo skin permeation. AAPS PharmSciTech, 25, 124 (2024) https://doi.org/10.1208/s12249-024-02831-9

Piumitali B, Neeraj U, Rupal D, Kumar PA. A comparative formulation development and evaluation of tazarotene ethosomal and transfersomal gel for effective management of acne. Int. J. Nanosci., 19, 2050005 (2020) https://doi.org/10.1142/S0219581X20500052

Ahmad J, Gautam A, Komath S, Bano M, Garg A, Jain K. Topical nano-emulgel for skin disorders: formulation approach and characterization. Recent Pat. Antiinfect. Drug Discov., 14, 36–48 (2019) https://doi.org/10.2174/1574891X14666181129115213

Gangurde AB, Pagar S. Preparation and Evaluation of Antibacterial Mupirocin Cream Emulsion Using Cocamidopropyl Betaine Emulsifier. Journal of Applied Pharmaceutical Research, 12, 215–24 (2024) https://doi.org/10.69857/joapr.v12i6.633.

Kanfer I, Rath S, Purazi P, Mudyahoto NA. In vitro release testing of semi-solid dosage forms. Dissolut. Technol., 24, 52–60 (2017) https://doi.org/10.14227/DT240317P52

de Almeida Borges VR, Simon A, Sena ARC, Cabral LM, de Sousa VP. Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation. Int. J. Nanomedicine, 8, 535–44 (2013) https://doi.org/10.2147/IJN.S39383

Tiwari P, Srivastava R. Formulation and evaluation of β-sitosterol loaded niosomes for enhanced antidiabetic activity: a potential alternative in type 2 diabetes management. Indian Drugs, 61, 45–51 (2024) https://doi.org/10.53879/id.61.05.14555

Patil A, Kontamwar P. Formulation and evaluation of antifungal nanogel for topical drug delivery system. Asian J. Pharm. Clin. Res., 14, 127–34 (2021) http://dx.doi.org/10.22159/ajpcr.2021v14i10.42421

Patel JA, Singh RP, Patel V, Goswami S. Application of mathematical models in drug release kinetics of Lagerstroemia speciosa extract–phospholipid complex. Res. J. Pharm. Technol., 15, 1257–62 (2022) https://doi.org/10.52711/0974-360X.2022.00210

Noor A, Jamil S, Sadeq TW, Mohammed Ameen MS, Kohli K. Development and evaluation of nanoformulations containing timur oil and rosemary oil for treatment of topical fungal infections. Gels, 9, 516 (2023) https://doi.org/10.3390/gels9070516

Prathvi S, Sandeep D, Jose J. Formulation and evaluation of luliconazole nanoemulgel using Box–Behnken design approach. Int. J. Appl. Pharm., 16, 211–23 (2024) https://doi.org/10.22159/ijap.2024v16i6.51522

Alhakamy NA, Md S, Alam MS, Shaik RA, Ahmad J, Ahmad A, Kutbi HI, Noor AO, Bagalagel A, Bannan DF. Development, optimization, and evaluation of luliconazole nanoemulgel for the treatment of fungal infection. J. Chem., 2021, 4942659 (2021) https://doi.org/10.1155/2021/4942659

Kumar TP, Eswaraiah MC. Formulation and evaluation of topical hydrogel containing antifungal drug. Pharm. Pharmacol. Int. J., 8, 249–54 (2020) https://doi.org/10.15406/ppij.2020.08.00302

Mahtab A, Anwar M, Mallick N, Naz Z, Jain GK, Ahmad FJ. Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS PharmSciTech, 17, 1477–90 (2016) https://doi.org/10.1208/s12249-016-0488-0

Sah SK, Badola A, Nayak BK. Emulgel: magnifying the application of topical drug delivery. Indian J. Pharm. Biol. Res., 5, 25–33 (2017) https://doi.org/10.30750/ijpbr.5.1.4